Description
Notes:
Sales, means the sales volume of Ligases
Revenue, means the sales value of Ligases
This report studies sales (consumption) of Ligases in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Thermo Fisher Scientific, Inc. (U.S.)
Merck KGaA (Germany)
New England Biolabs, Inc. (U.S.)
Promega (U.S.)
Illumina, Inc. (U.S.)
Agilent Technologies, Inc. (U.S.)
F. Hoffmann-la Roche Ltd. (Switzerland)
Takara Bio Inc. (Japan)
QIAGEN N.V. (The Netherlands)
Becton, Dickinson and Company (U.S.)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Ligases in these regions, from 2011 to 2021 (forecast), like
USA
China
Europe
Japan
India
Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Ligases in each application, can be divided into
PCR
Sequencing
Cloning
Table of contents
Table of Contents
Global Ligases Sales Market Report 2016
1 Ligases Overview
1.1 Product Overview and Scope of Ligases
1.2 Classification of Ligases
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Ligases
1.3.1 PCR
1.3.2 Sequencing
1.3.3 Cloning
1.4 Ligases Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Ligases (2011-2021)
1.5.1 Global Ligases Sales and Growth Rate (2011-2021)
1.5.2 Global Ligases Revenue and Growth Rate (2011-2021)2 Global Ligases Competition by Manufacturers, Type and Application
2.1 Global Ligases Market Competition by Manufacturers
2.1.1 Global Ligases Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Ligases Revenue and Share by Manufacturers (2011-2016)
2.2 Global Ligases (Volume and Value) by Type
2.2.1 Global Ligases Sales and Market Share by Type (2011-2016)
2.2.2 Global Ligases Revenue and Market Share by Type (2011-2016)
2.3 Global Ligases (Volume and Value) by Regions
2.3.1 Global Ligases Sales and Market Share by Regions (2011-2016)
2.3.2 Global Ligases Revenue and Market Share by Regions (2011-2016)
2.4 Global Ligases (Volume) by Application3 USA Ligases (Volume, Value and Sales Price)
3.1 USA Ligases Sales and Value (2011-2016)
3.1.1 USA Ligases Sales and Growth Rate (2011-2016)
3.1.2 USA Ligases Revenue and Growth Rate (2011-2016)
3.1.3 USA Ligases Sales Price Trend (2011-2016)
3.2 USA Ligases Sales and Market Share by Manufacturers
3.3 USA Ligases Sales and Market Share by Type
3.4 USA Ligases Sales and Market Share by Application4 China Ligases (Volume, Value and Sales Price)
4.1 China Ligases Sales and Value (2011-2016)
4.1.1 China Ligases Sales and Growth Rate (2011-2016)
4.1.2 China Ligases Revenue and Growth Rate (2011-2016)
4.1.3 China Ligases Sales Price Trend (2011-2016)
4.2 China Ligases Sales and Market Share by Manufacturers
4.3 China Ligases Sales and Market Share by Type
4.4 China Ligases Sales and Market Share by Application5 Europe Ligases (Volume, Value and Sales Price)
5.1 Europe Ligases Sales and Value (2011-2016)
5.1.1 Europe Ligases Sales and Growth Rate (2011-2016)
5.1.2 Europe Ligases Revenue and Growth Rate (2011-2016)
5.1.3 Europe Ligases Sales Price Trend (2011-2016)
5.2 Europe Ligases Sales and Market Share by Manufacturers
5.3 Europe Ligases Sales and Market Share by Type
5.4 Europe Ligases Sales and Market Share by Application6 Japan Ligases (Volume, Value and Sales Price)
6.1 Japan Ligases Sales and Value (2011-2016)
6.1.1 Japan Ligases Sales and Growth Rate (2011-2016)
6.1.2 Japan Ligases Revenue and Growth Rate (2011-2016)
6.1.3 Japan Ligases Sales Price Trend (2011-2016)
6.2 Japan Ligases Sales and Market Share by Manufacturers
6.3 Japan Ligases Sales and Market Share by Type
6.4 Japan Ligases Sales and Market Share by Application7 India Ligases (Volume, Value and Sales Price)
7.1 India Ligases Sales and Value (2011-2016)
7.1.1 India Ligases Sales and Growth Rate (2011-2016)
7.1.2 India Ligases Revenue and Growth Rate (2011-2016)
7.1.3 India Ligases Sales Price Trend (2011-2016)
7.2 India Ligases Sales and Market Share by Manufacturers
7.3 India Ligases Sales and Market Share by Type
7.4 India Ligases Sales and Market Share by Application8 Southeast Asia Ligases (Volume, Value and Sales Price)
8.1 Southeast Asia Ligases Sales and Value (2011-2016)
8.1.1 Southeast Asia Ligases Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Ligases Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Ligases Sales Price Trend (2011-2016)
8.2 Southeast Asia Ligases Sales and Market Share by Manufacturers
8.3 Southeast Asia Ligases Sales and Market Share by Type
8.4 Southeast Asia Ligases Sales and Market Share by Application9 Global Ligases Manufacturers Analysis
9.1 Thermo Fisher Scientific, Inc. (U.S.)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Ligases Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Thermo Fisher Scientific, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Merck KGaA (Germany)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 126 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Merck KGaA (Germany) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 New England Biolabs, Inc. (U.S.)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 144 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 New England Biolabs, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Promega (U.S.)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sept Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Promega (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Illumina, Inc. (U.S.)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Illumina, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Agilent Technologies, Inc. (U.S.)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Agilent Technologies, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 F. Hoffmann-la Roche Ltd. (Switzerland)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Takara Bio Inc. (Japan)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Takara Bio Inc. (Japan) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 QIAGEN N.V. (The Netherlands)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 QIAGEN N.V. (The Netherlands) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Becton, Dickinson and Company (U.S.)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Becton, Dickinson and Company (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview10 Ligases Maufacturing Cost Analysis
10.1 Ligases Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Ligases11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Ligases Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Ligases Major Manufacturers in 2015
11.4 Downstream Buyers12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change14 Global Ligases Market Forecast (2016-2021)
14.1 Global Ligases Sales, Revenue Forecast (2016-2021)
14.2 Global Ligases Sales Forecast by Regions (2016-2021)
14.3 Global Ligases Sales Forecast by Type (2016-2021)
14.4 Global Ligases Sales Forecast by Application (2016-2021)15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
